Search clinical trials for: Asthma, COPD, broncodilator, airway, lung, inhalation, antimuscarinic
Total 100 results
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease, COPDPoland, United States
-
Deep BreezeCompletedChronic Obstructive Pulmonary Disease | AsthmaUnited States
-
University of MiamiMerck Sharp & Dohme LLCCompleted
-
University of MiamiWithdrawn
-
Leiden University Medical CenterThe Netherlands Asthma FoundationUnknownChronic Obstructive Pulmonary Disease | AsthmaNetherlands
-
Washington University School of MedicineAmerican Academy of Clinical ToxicologyNot yet recruitingAnticholinergic ToxicityUnited States
-
Washington University School of MedicineAmerican Academy of Clinical ToxicologyNot yet recruiting
-
National Taiwan University HospitalNot yet recruitingUrinary Bladder, Overactive | Urinary Incontinence | Pelvic Organ Prolapse | Urinary Bladder Neck ObstructionTaiwan
-
Pamukkale UniversityNot yet recruitingUrinary Bladder, OveractiveTurkey
-
AstraZenecaCompletedAsthmaTaiwan, Korea, Republic of, Philippines, China
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan
-
Riphah International UniversityCompleted
-
Imperial College LondonGlaxoSmithKlineTerminated
-
Far Eastern Memorial HospitalNational Science Council, TaiwanCompletedOveractive Bladder Syndrome | Lower Urinary Tract DysfunctionTaiwan
-
Novartis PharmaceuticalsCompletedRetinopathy of Prematurity (ROP)United States, Austria, Belgium, Croatia, Czechia, Denmark, Egypt, France, Germany, Greece, Hungary, India, Italy, Japan, Malaysia, Romania, Russian Federation, Saudi Arabia, Slovakia, Taiwan, Turkey, United Kingdom, Lithuania, Estonia
-
Hospices Civils de LyonTerminatedAcute Respiratory Distress Syndrome (ARDS)France
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorSpain, Singapore, Japan, United States, Canada
-
University of Colorado, DenverAmerican Academy of Clinical ToxicologyCompletedAnticholinergics ToxicityUnited States
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Netherlands, United Kingdom
-
Bayside HealthNewcastle University; Austin HealthCompleted
-
Adana Numune Training and Research HospitalCompletedHuman Papilloma Virus | Atopic Asthma | Atopic DisordersTurkey
-
Novartis PharmaceuticalsCompleted
-
Assistance Publique - Hôpitaux de ParisVaincre la MucoviscidoseCompleted
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Australia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Poland, Romania, Hungary, Sweden, Russian Federation, Bulgaria, Finland, Israel, Belgium
-
Stéphane BolducPfizerCompletedOveractive BladderCanada
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseCanada
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteCompletedAsthma | CommunicationUnited States
-
University Hospital, Strasbourg, FranceUnknown
-
University of Alabama at BirminghamAllerganCompletedFecal Incontinence | Urinary Incontinence, UrgeUnited States
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, Belgium, Latvia, Lithuania, Japan
-
AstraZenecaCompleted
-
Astellas Scientific & Medical Affairs, Inc.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Canada
-
Hai Yen Eye CareBrien Holden VisionCompleted
-
Ankara Training and Research HospitalMinistry of Health, TurkeyCompleted
-
CHU de Quebec-Universite LavalCompletedOveractive Bladder | Urinary Incontinence
-
AstraZenecaCompleted
-
CHU de Quebec-Universite LavalCompletedOveractive Bladder | Urinary Incontinence
-
Samsung Medical CenterCompleted
-
GlaxoSmithKlineCompleted
-
AstraZenecaCompletedAsthmaUnited States, Canada, Germany, Poland, Hungary, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
AstraZenecaCompletedAsthmaUnited States, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Vietnam
-
The Cleveland ClinicPfizerUnknown
-
Stanford UniversityAllerganCompletedUrinary Incontinence | Parkinson's Disease | Neurogenic Bladder | Clostridium Botulinum Toxin Adverse ReactionUnited States
-
Buddhist Tzu Chi General HospitalCompleted
-
AstraZenecaCompletedEfficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsChronic Obstructive Pulmonary Disease (COPD)Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom